Ledger.Open graph →
SEC Form D · filed June 17, 2015

Gemstone BioTherapeutics, LLC

Offering
$1.6M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

David Oros · Baltimore, MDDirector · PromoterSharon Gerecht · Baltimore, MDDirectorGeorge Davis · Pasadena, MDExec · Director · PromoterXin Huang · Baltimore, MDDirectorSharon Gerecht · Baltimore, MDDirectorGeorge Davis · Baltimore, MDExec · Director · PromoterXin Huang · Baltimore, MDDirectorDavid Oros · Baltimore, MDDirector · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗